SEC Filings for Outlook Therapeutics Inc. (OTLK)

$ 0.56   -0.0121 (-2.12%) Volume: 179.21k 3:59 PM EDT Apr 7, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)304/02/2020
8-KCurrent report pursuant to Section 13 or 15(d)603/24/2020
SC 13D/A[Amend] General statement of acquisition of beneficial ownership1103/24/2020
4Statement of changes in beneficial ownership of securities103/23/2020
4Statement of changes in beneficial ownership of securities103/20/2020
4Statement of changes in beneficial ownership of securities103/20/2020
4Statement of changes in beneficial ownership of securities103/20/2020
4Statement of changes in beneficial ownership of securities103/20/2020
4Statement of changes in beneficial ownership of securities103/20/2020
DNotice of Exempt Offering of Securities103/11/2020
DEFA14AAdditional proxy soliciting materials - definitive503/10/2020
SC 13GStatement of acquisition of beneficial ownership by individuals903/05/2020
4Statement of changes in beneficial ownership of securities102/27/2020
SC 13D/A[Amend] General statement of acquisition of beneficial ownership1502/27/2020
3Initial statement of beneficial ownership of securities202/27/2020
<<
First
<
Prev
123456789101112131415